Evidence map›Paper›PMID 35056426›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19-A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan.

Shinobu Tamura, Takahiro Kaki, Mayako Niwa, Yukiko Yamano, Shintaro Kawai, Yusuke Yamashita, Harumi Tanaka, Yoshinobu Saito, Yoshinori Kajimoto, Yusuke Koizumi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Shinobu TamuraDepartment of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.ORCID 0000-0002-1150-0970
Takahiro KakiDepartment of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Mayako NiwaDepartment of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Yukiko YamanoDepartment of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Shintaro KawaiDepartment of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Yusuke YamashitaDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan.
Harumi TanakaDepartment of Nursing, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Yoshinobu SaitoDepartment of Pharmacy, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Yoshinori KajimotoDepartment of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Yusuke KoizumiDepartment of Infection Control and Prevention, Wakayama Medical University, Wakayama 6418509, Japan.
Hiroki YamaueSecond Department of Surgery, Wakayama Medical University, Wakayama 6418509, Japan.
Naoyuki NakaoDepartment of Neurosurgery, Wakayama Medical University, Wakayama 6418509, Japan.
Takako NojiriWakayama Prefecture, Health Department, Wakayama 6408585, Japan.
Masaya HironishiDepartment of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.
Wakayama Medical University · JPWakayama Prefecture Wakayama School for the Blind · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentSARS-CoV-2Adenosine MonophosphateAlanineHumansJapanMiddle AgedPandemicsRetrospective StudiesRisk FactorsAdenosine MonophosphateAlanineremdesivirB.1.1.7 variantCOVID-19headachehospitalizationremdesivir

Identifiers

PMID35056426
PMCPMC8779147
OpenAlexW4206513291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.